Trade Ideas
Actionable trade ideas with entry/stop/target and risk framing.
JFrog: Growth Re-Acceleration, Positive Cash Flow and a Swing Trade Setup
Revenue momentum + clean balance sheet supports a tactical long; valuation still demands execution.
JFrog reported a clear re-acceleration in top-line growth through Q3 FY2025 (filed 11/07/2025) while generating meaningful operating cash flow. The st...
Great Lakes Dredge & Dock (GLDD) - Visible Earnings Recovery; Tactical Long with Defined Risk
Strong cash flows, improving operating margins and heavy project backlog make GLDD a tradeable long — small-cap exposure to infrastructure tailwinds.
Great Lakes Dredge & Dock has shown step-up in profitability and cash generation across 2025 quarters. With operating cash flow running high while the...
Mastercard: Keep Swiping — Buy the Dip, Ride the Volume Tailwind
High margins, strong free cash flow and share buybacks support a tactical long with clear entry, stop and targets.
Mastercard remains a high-quality payments franchise: processed nearly $10 trillion in 2024, shows steady revenue and earnings expansion across 2025 q...
Buy IONQ After SkyWater Deal - A Vertical-Integration Re-rate Trade
SkyWater acquisition + large financing create a binary setup; entry, stops and targets for a high-risk long.
IonQ's recent balance-sheet reshaping and the announced SkyWater chipmaker deal create an actionable long trade. The company shows accelerating revenu...
Quest Diagnostics (DGX) — Buy the Durable Testing Platform; Trade Plan with Income and Upside
Lab leader delivering steady cash flow, margin resilience and a reliable yield — tactical long with tight risk control.
Quest Diagnostics is the largest independent clinical diagnostics provider in the U.S. Recent results show durable revenue (Q3 FY2025 revenue $2.816B)...
Momentum Trade: Relay Therapeutics (+RLY) — Buy the Zovegalisib-Driven Pop, Tight Risk Control
Market optimism around RLY-2608 data and reported analyst interest has pushed shares higher; bankroll the rally with a defined entry, stop and upside targets
Relay Therapeutics is trading up after fresh clinical interest in its PI3Kα inhibitor RLY-2608 (zovegalisib). The company has a clean balance sheet (...
Pagaya (PGY): Cash-Generating AI-Fintech — A Tactical Long with Asymmetric Upside
Revenue momentum, positive operating cash flow and a sub-1.5x P/S create a risk-reward skew for patient swing/position buyers.
Pagaya has moved from growth-at-all-costs to a clearer profit and cash-flow profile while maintaining revenue acceleration. With an implied market cap...
Why 2026 Could Be an EPYC-Driven Re-rating for AMD: Trade Plan and Risks
AI GPUs help, but enterprise EPYC share gains and improving cash conversion are the cleaner trade
AMD finished FY2025 Q3 (period ended 09/27/2025) with accelerating revenue, a strong gross margin (~52%) and positive operating leverage. Investors ar...
Dave: Rapid Top-Line Momentum, But Credit Risk Makes This a Tactical Short
Strong revenue and operating-cash conversion are real — but potential delinquencies and volatile one-time items make the equity a high-risk trade at current levels
Dave Inc. is growing revenue quickly and producing robust operating cash flow, but outsized loan-loss provisions in prior cycles and an earnings mix t...
Duos Technologies (DUOT) - High Growth, Deep Value Optionality in Edge AI and Rail Automation
A tactical long for growth investors: entry, stop, and multi-horizon targets based on acceleration in revenue, fresh capital and edge data center rollout.
Duos Technologies is executing a two-pronged growth play: recurring, software-driven revenue from rail and logistics (RIP and ALIS) plus a nascent but...
Rekor Systems: Small-Cap AI Play at an Operational Inflection - Tactical Long Idea
Sequential revenue gains and narrower operating losses set up a defined swing trade with asymmetric upside vs. capital at risk.
Rekor (REKR) is a tiny, under-followed provider of AI-driven roadway intelligence. Recent quarterly results show sequential revenue acceleration (Q1->...
Avita Medical (RCEL) - Single-Product Turnaround Setup; Tactical Long With Defined Risk/Reward
RECELL adoption + tighter cost control vs. investigation overhang - asymmetric swing trade if you size it.
Avita Medical is a small-cap, single-product medical device company whose RECELL spray-on skin technology faces near-term legal and reimbursement nois...